Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/1995
05/26/1995WO1995013805A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
05/26/1995WO1995013803A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
05/26/1995WO1995013801A1 Fatty acid delivery system
05/26/1995CA2176747A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
05/26/1995CA2176735A1 Non-peptide tachykinin receptor antagonists
05/26/1995CA2176507A1 Endothelin-converting enzyme
05/26/1995CA2176143A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
05/24/1995EP0654479A2 Esculetin derivatives and method for manufacture thereof, use thereof, and pharmaceutical composition
05/24/1995EP0654077A1 Method and reagent for treatment of animal diseases
05/24/1995EP0654041A1 Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents
05/24/1995EP0654029A1 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists
05/24/1995EP0653943A1 Targeting somatic gene therapy to joints
05/23/1995US5418233 For inhibiting cell aggregation
05/18/1995WO1995013380A2 Method and reagent for treatment of arthritic conditions
05/18/1995WO1995013289A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/18/1995WO1995013287A1 New steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances
05/18/1995WO1995013277A1 6-oxo-nucleosides useful as immunosuppressants
05/18/1995WO1995013262A1 Substituted phenyl compounds
05/18/1995WO1995013086A1 Cytokine restraining agents
05/18/1995WO1995013071A2 Treatment of immunoregulatory disorders
05/18/1995WO1995013067A1 Oxazoles for treating cytokine mediated diseases
05/18/1995WO1995013064A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/18/1995WO1995013062A1 Butyric ester cyto-differentiating agents
05/18/1995CA2176368A1 New steroids with radicophilic substituents, a process for manufacturing these, and medications that contain these compounds
05/18/1995CA2176363A1 Substituted phenyl compounds
05/18/1995CA2176124A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/18/1995CA2176013A1 Treatment of immunoregulatory disorders
05/18/1995CA2175897A1 6-oxo-nucleosides useful as immunosuppressants
05/18/1995CA2175824A1 Method and reagent for treatment of arthritic conditions
05/18/1995CA2175249A1 Butyric ester cyto-differentiating agents
05/18/1995CA2173470A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/17/1995EP0652903A1 NEW HUMAN RECOMBINANT $g(g) INTERFERON
05/17/1995EP0652897A1 Peptide inhibitors of selectin binding
05/17/1995EP0652893A1 Kininogenase inhibitors
05/17/1995EP0652874A1 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
05/17/1995EP0652872A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds
05/17/1995EP0652868A1 INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF
05/17/1995EP0652866A1 Azacyclic compounds
05/17/1995EP0652864A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds
05/17/1995EP0652863A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression
05/17/1995EP0652759A1 Ibuprofen-antacid combinations
05/17/1995EP0365613B1 Combination of tobramycin and steroids for topical ophthalmic use
05/16/1995US5416194 Extracted from horseshoe crab
05/16/1995US5416117 Cyclopropenone derivatives
05/16/1995US5416112 Antiinflammatory agents
05/16/1995US5416098 Antiallergens
05/16/1995US5416087 Bis-benzo, cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use
05/16/1995CA1335592C Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds
05/16/1995CA1335590C Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
05/16/1995CA1335577C Superoxide dismutase analogs having novel binding properties
05/11/1995WO1995012673A1 Receptor on the surface of activated t-cells: acts-4
05/11/1995WO1995012603A1 Matrix metalloprotease inhibitors________________________________
05/11/1995WO1995012589A1 Process for the preparation of n-4-[(substituted phenyl)alkylthienyl]-, and n-4-[(substituted phenyl)alkylfuryl]but-3-yn-2-yl]-n-hydroxyurea compounds
05/11/1995WO1995012581A1 Pseudodipeptide product having an imidazole grouping and applications
05/11/1995WO1995012416A1 Treatment for rheumatoid arthritis
05/11/1995WO1995012415A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions
05/11/1995WO1995012394A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995WO1995012389A1 Multilamellar liposomal arachidonic acid metabolite formulations
05/11/1995WO1995012388A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2175902A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions
05/11/1995CA2175896A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2175667A1 Matrix metalloprotease inhibitors________________________________
05/11/1995CA2175467A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995CA2175457A1 Treatment for rheumatoid arthritis
05/11/1995CA2175057A1 Multilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2174548A1 Process for the preparation of n-4-¬(substituted phenyl)alkylthienyl|-, and n-4-¬(substituted phenyl)alkylfuryl|but-3-yn-2-yl|-n-hydroxyurea compounds
05/11/1995CA2135440A1 Heterocyclic compounds, their production and use
05/10/1995EP0652218A1 Heterocyclic compounds, their production and use
05/10/1995EP0652214A1 N-Aryl-2-cyano-3-hydroxy propenamide derivatives, a method for their preparation, their use as medicaments and pharmaceutical compositions containing them
05/10/1995EP0652208A1 Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity
05/10/1995EP0652010A1 Use of alphatocopherol acetate or a derivative for the preparation of cosmetic, dermatalogical or pharmaceutical compositions with anti radical activity
05/10/1995EP0651800A1 Basophil granule proteins
05/10/1995EP0651756A1 Tricyclic defem sulphones as elastase inhibitors
05/10/1995EP0651743A1 Indolinyl n-hydroxyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors
05/10/1995EP0651738A1 Natural amino acid derivatives as metalloproteinase inhibitors
05/10/1995EP0651654A1 Lysozyme dimer and compositions containing the same
05/10/1995EP0651645A1 Medicament for inhibiting neutrophil elastase and cathepsin g
05/10/1995EP0651641A1 Novel bioactive compositions, preparation and use thereof
05/10/1995CN1028367C Nonsaditive antihistaminics derived from benzimidazoles
05/09/1995US5414011 Preservative system for ophthalmic formulations
05/09/1995US5413996 Targeted drug delivery via phosphonate derivatives
05/09/1995US5413776 Pharmaceutical preparation for percutaneous absorption
05/06/1995CA2135000A1 Isoquinolines
05/05/1995CA2135044A1 N-aryl-2-cyano-3-hydroxypropenamides derivatives, proc ess for their preparation, their application as medicaments and pharmaceutical compositions containing them
05/04/1995WO1995011987A1 Chimeric proteins including protease nexin-1 variants
05/04/1995WO1995011908A1 Novel phosphorus-containing spin-trap compositions
05/04/1995WO1995011883A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/04/1995WO1995011881A1 Phytosphingosine-based ceramide i analogs
05/04/1995WO1995011702A1 Prokaryotic expression of mhc proteins
05/04/1995WO1995011687A1 Therapeutic use of cis-element decoys in vivo
05/04/1995WO1995011669A1 Suspension of loteprednol etabonate
05/04/1995WO1995006077A3 Polymeric matrices and their uses in pharmaceutical compositions
05/04/1995CA2175089A1 Prokaryotic expression of mhc proteins
05/04/1995CA2170736A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/04/1995CA2152363A1 Novel phosphorus-containing spin-trap compositions
05/03/1995EP0650721A1 Cyclosporin soft capsule
05/03/1995EP0650496A1 Anti-inflammatory compounds for ophthalmic use
05/03/1995EP0650494A1 Gastrointestinal defensins, cdna sequences and method for the production and use thereof
05/03/1995EP0650493A1 Hybrid oligonucleotide phosphorothioates
05/03/1995EP0650492A1 Reducing inflammation by time dependent administration of oligosaccharides glycosides related to blood group determinants
1 ... 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 ... 1272